X-linked Nonsyndromic Hearing Loss

Genetic MONDO:0019586 Pathograph 9 Nonsyndromic Hearing Loss X-linked Deafness

X-linked nonsyndromic hearing loss, also called DFNX, is a genetically heterogeneous form of hereditary hearing loss caused by germline variants in X-chromosome genes required for cochlear development, hair-cell function, or auditory pathway integrity. Current evidence highlights PRPS1, POU3F4, SMPX, AIFM1, and COL4A6 as principal DFNX genes. POU3F4 is the most common X-linked nonsyndromic hearing-loss gene and is strongly associated with incomplete partition type III inner-ear malformation. X-linked cases usually begin congenitally or in childhood; males are typically more severely affected, while females can show variable expressivity.

Ask OpenScientist

Ask a research question about X-linked Nonsyndromic Hearing Loss. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
3
Pathophys.
4
Phenotypes
9
Pathograph
5
Genes
2
Treatments
5
Subtypes
1
Deep Research
👪

Inheritance

1
X-linked inheritance HP:0001417
DFNX is caused by pathogenic variants in genes on the X chromosome. Hemizygous males are typically more severely affected, and heterozygous females may show variable expressivity.
X-linked inheritance
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"X-linked HL was congenital or began during childhood in all cases, with representative audiological profiles or typical cochlear malformations in certain genes."
The cohort describes X-linked hereditary hearing-loss cases and their early-onset clinical presentation.
◆

Subtypes

5
DFNX1 / PRPS1-related X-linked nonsyndromic hearing loss MONDO:0010577
PRPS1 link
PRPS1-related DFNX1 is the mild, isolated-hearing-loss end of the PRPS1 deficiency spectrum. Reported cases may show progressive sensorineural hearing loss from congenital through childhood or teenage onset.
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"causative variants in PRPS1 and AIFM1 were mainly of the missense type, suggesting that phenotypic variability was correlated with the different effects that the replaced residues exert on structure and function."
The cohort review identifies PRPS1 among X-linked hereditary hearing-loss genes and describes the main variant class and genotype-phenotype interpretation.
DFNX2 / DFN3 / POU3F4-related X-linked hearing loss MONDO:0010576
POU3F4 link
POU3F4-related DFNX2/DFN3 is the most frequent X-linked nonsyndromic hearing-loss subtype and is characterized by severe congenital or childhood hearing loss with incomplete partition type III inner-ear malformation in many affected individuals.
Show evidence (1 reference)
PMID:37371790 SUPPORT Other
"POU3F4 is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked non-syndromic hearing loss."
This review establishes POU3F4 as the main DFNX gene and links it to the DFNX2/DFN3 subtype.
DFNX4 / SMPX-related X-linked nonsyndromic hearing loss MONDO:0010238
SMPX link
SMPX-related DFNX4 is usually progressive nonsyndromic hearing loss. Truncating SMPX variants are associated with DFNX4 auditory phenotypes, while nontruncating variants can be associated with non-auditory myopathy phenotypes.
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"Variations in SMPX causing truncation of the protein product were associated with DFNX4, which resulted in typical audiological profiles before and after the age of 10 years"
The cohort synthesis supports SMPX truncating variants as a DFNX4 cause and describes the age-related audiological profile.
DFNX5 / AIFM1-related X-linked hearing loss MONDO:0010378
AIFM1 link
AIFM1-related DFNX5 is an X-linked hearing-loss subtype in which reported causative variants are mainly missense and phenotype depends on the structural and functional impact of the substituted residue.
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"causative variants in PRPS1 and AIFM1 were mainly of the missense type, suggesting that phenotypic variability was correlated with the different effects that the replaced residues exert on structure and function."
The cohort synthesis supports AIFM1 as a DFNX gene and summarizes the main variant class.
DFNX6 / COL4A6-related X-linked hearing loss MONDO:0010484
COL4A6 link
COL4A6-related DFNX6 is an X-linked hearing-loss subtype reported in molecular cohorts; the abstract-supported evidence identifies COL4A6 as one of the genes contributing to X-linked hereditary hearing loss.
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"the aggregate contribution of HL caused by genes on the X chromosome in this cohort was ~ 1.14% (22/1922), and POU3F4 variants caused ~ 59% (13/22) of these cases."
This molecular epidemiology study supports the broader X-linked gene category that includes COL4A6 in the Falcon report, while the abstract does not provide COL4A6-specific phenotype details.
⚙

Pathophysiology

3
X-linked genetic heterogeneity in cochlear disease
X-linked nonsyndromic hearing loss is not a single molecular mechanism but a category of X-chromosome gene defects affecting auditory development and function. Molecular diagnosis links the auditory phenotype to genes such as PRPS1, POU3F4, SMPX, AIFM1, and COL4A6.
Downstream
Sensorineural hearing impairment Gene-specific disruption of auditory development or function produces isolated hearing impairment.
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"We also discussed the clinical features associated with X-linked non-syndromic HL-related genes based on a review of the literature."
The study frames DFNX as a multi-gene X-linked hearing-loss category.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for X-linked Nonsyndromic Hearing Loss Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

4
Ear 1
Sensorineural hearing impairment Sensorineural hearing impairment (HP:0000407)
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"X-linked HL was congenital or began during childhood in all cases, with representative audiological profiles or typical cochlear malformations in certain genes."
The cohort directly describes early onset of X-linked hereditary hearing-loss cases.
Other 3
Progressive sensorineural hearing impairment Progressive sensorineural hearing impairment (HP:0000408)
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"Variations in SMPX causing truncation of the protein product were associated with DFNX4, which resulted in typical audiological profiles before and after the age of 10 years"
The cohort summary supports an age-related audiological profile in SMPX-related DFNX4.
Incomplete partition type III Cochlear malformation (HP:0008554)
Show evidence (2 references)
PMID:37371790 SUPPORT Other
"The clinical features of POU3F4-related hearing loss include a pathognomonic malformation of the inner ear defined as incomplete partition of the cochlea type 3 (IP-III)."
The review directly supports IP-III as the characteristic POU3F4-related malformation.
PMID:38498189 SUPPORT Other
"Mutations in the POU3F4 gene emerge as the principal pathogenic contributors to IP-III anomalies"
The IP-III review independently supports POU3F4 as the principal genetic contributor to this malformation.
Perilymphatic gusher during stapedectomy
Show evidence (1 reference)
PMID:37371790 SUPPORT Other
"Often, a perilymphatic gusher is observed upon stapedectomy during surgery, possibly as a consequence of an incomplete separation of the cochlea from the internal auditory canal."
The POU3F4 review directly supports perilymphatic gusher as a DFNX2-relevant surgical phenotype.
🧬

Genetic Associations

5
PRPS1 pathogenic variants (Causal)
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"causative variants in PRPS1 and AIFM1 were mainly of the missense type, suggesting that phenotypic variability was correlated with the different effects that the replaced residues exert on structure and function."
The cohort supports PRPS1 pathogenic variants as a cause of X-linked hereditary hearing loss.
POU3F4 pathogenic variants (Causal)
Show evidence (1 reference)
PMID:37371790 SUPPORT Other
"POU3F4 is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked non-syndromic hearing loss."
Review-level evidence supports POU3F4 as the most common DFNX gene.
SMPX pathogenic variants (Causal)
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"Variations in SMPX causing truncation of the protein product were associated with DFNX4, which resulted in typical audiological profiles before and after the age of 10 years"
The cohort supports truncating SMPX variants as DFNX4-associated.
AIFM1 pathogenic variants (Causal)
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"causative variants in PRPS1 and AIFM1 were mainly of the missense type, suggesting that phenotypic variability was correlated with the different effects that the replaced residues exert on structure and function."
The cohort supports AIFM1 pathogenic variants as a cause of X-linked hereditary hearing loss.
COL4A6 pathogenic variants (Causal)
Show evidence (1 reference)
PMID:39272213 PARTIAL Human Clinical
"No phenotypic differences were identified in patients carrying POU3F4 or COL4A6 variants."
The abstract specifically mentions patients carrying COL4A6 variants but gives limited COL4A6-specific mechanism or phenotype detail, so this assertion remains partial.
💊

Treatments

2
Cochlear implantation for POU3F4/IP-III anatomy
Action: cochlear implantation Ontology label: implantation MAXO:0000451
Cochlear implantation is a major intervention for severe POU3F4-related IP-III hearing loss, but the malformation increases surgical complexity and requires careful preoperative assessment and postoperative verification.
Target Phenotypes: Sensorineural hearing impairment ↗
Show evidence (1 reference)
PMID:38498189 SUPPORT Other
"cochlear implantation currently serving as the predominant therapeutic approach."
The IP-III review supports cochlear implantation as the predominant therapeutic approach for this malformation-associated form of X-linked deafness.
Genetic Counseling
Action: genetic counseling MAXO:0000079
Genetic counseling is important for recurrence-risk counseling, sex-linked inheritance counseling, and genotype-informed management decisions in DFNX families.
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"Analysis of the genotype-phenotype relationship is valuable for X-linked HL precise diagnostics and genetic counseling."
The cohort conclusion directly supports genetic counseling as a management implication of genotype-phenotype analysis.
{ }

Source YAML

click to show 
name: X-linked Nonsyndromic Hearing Loss
creation_date: "2026-05-08T00:00:00Z"
updated_date: "2026-05-08T17:44:01Z"
description: >-
  X-linked nonsyndromic hearing loss, also called DFNX, is a genetically
  heterogeneous form of hereditary hearing loss caused by germline variants in
  X-chromosome genes required for cochlear development, hair-cell function, or
  auditory pathway integrity. Current evidence highlights PRPS1, POU3F4, SMPX,
  AIFM1, and COL4A6 as principal DFNX genes. POU3F4 is the most common
  X-linked nonsyndromic hearing-loss gene and is strongly associated with
  incomplete partition type III inner-ear malformation. X-linked cases usually
  begin congenitally or in childhood; males are typically more severely
  affected, while females can show variable expressivity.
category: Genetic
disease_term:
  preferred_term: X-linked nonsyndromic hearing loss
  term:
    id: MONDO:0019586
    label: X-linked nonsyndromic hearing loss
parents:
- Nonsyndromic Hearing Loss
- X-linked Deafness
synonyms:
- X-linked nonsyndromic deafness
- X-linked non-syndromic sensorineural hearing loss type DFN
- X-linked isolated sensorineural hearing loss type DFN
has_subtypes:
- name: DFNX1
  display_name: DFNX1 / PRPS1-related X-linked nonsyndromic hearing loss
  classification: molecular
  subtype_term:
    preferred_term: hearing loss, X-linked 1
    term:
      id: MONDO:0010577
      label: hearing loss, X-linked 1
  description: >-
    PRPS1-related DFNX1 is the mild, isolated-hearing-loss end of the PRPS1
    deficiency spectrum. Reported cases may show progressive sensorineural
    hearing loss from congenital through childhood or teenage onset.
  genes:
  - preferred_term: PRPS1
    term:
      id: hgnc:9462
      label: PRPS1
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      causative variants in PRPS1 and AIFM1 were mainly of the missense type,
      suggesting that phenotypic variability was correlated with the different
      effects that the replaced residues exert on structure and function.
    explanation: >-
      The cohort review identifies PRPS1 among X-linked hereditary hearing-loss
      genes and describes the main variant class and genotype-phenotype
      interpretation.
- name: DFNX2
  display_name: DFNX2 / DFN3 / POU3F4-related X-linked hearing loss
  classification: molecular
  subtype_term:
    preferred_term: X-linked mixed hearing loss with perilymphatic gusher
    term:
      id: MONDO:0010576
      label: X-linked mixed hearing loss with perilymphatic gusher
  description: >-
    POU3F4-related DFNX2/DFN3 is the most frequent X-linked nonsyndromic
    hearing-loss subtype and is characterized by severe congenital or childhood
    hearing loss with incomplete partition type III inner-ear malformation in
    many affected individuals.
  genes:
  - preferred_term: POU3F4
    term:
      id: hgnc:9217
      label: POU3F4
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      POU3F4 is the gene most commonly associated with X-linked deafness
      (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked
      non-syndromic hearing loss.
    explanation: >-
      This review establishes POU3F4 as the main DFNX gene and links it to the
      DFNX2/DFN3 subtype.
- name: DFNX4
  display_name: DFNX4 / SMPX-related X-linked nonsyndromic hearing loss
  classification: molecular
  subtype_term:
    preferred_term: hearing loss, X-linked 4
    term:
      id: MONDO:0010238
      label: hearing loss, X-linked 4
  description: >-
    SMPX-related DFNX4 is usually progressive nonsyndromic hearing loss.
    Truncating SMPX variants are associated with DFNX4 auditory phenotypes,
    while nontruncating variants can be associated with non-auditory myopathy
    phenotypes.
  genes:
  - preferred_term: SMPX
    term:
      id: hgnc:11122
      label: SMPX
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Variations in SMPX causing truncation of the protein product were
      associated with DFNX4, which resulted in typical audiological profiles
      before and after the age of 10 years
    explanation: >-
      The cohort synthesis supports SMPX truncating variants as a DFNX4 cause
      and describes the age-related audiological profile.
- name: DFNX5
  display_name: DFNX5 / AIFM1-related X-linked hearing loss
  classification: molecular
  subtype_term:
    preferred_term: X-linked hereditary sensory and autonomic neuropathy with hearing loss
    term:
      id: MONDO:0010378
      label: X-linked hereditary sensory and autonomic neuropathy with hearing loss
  description: >-
    AIFM1-related DFNX5 is an X-linked hearing-loss subtype in which reported
    causative variants are mainly missense and phenotype depends on the
    structural and functional impact of the substituted residue.
  genes:
  - preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      causative variants in PRPS1 and AIFM1 were mainly of the missense type,
      suggesting that phenotypic variability was correlated with the different
      effects that the replaced residues exert on structure and function.
    explanation: >-
      The cohort synthesis supports AIFM1 as a DFNX gene and summarizes the
      main variant class.
- name: DFNX6
  display_name: DFNX6 / COL4A6-related X-linked hearing loss
  classification: molecular
  subtype_term:
    preferred_term: hearing loss, X-linked 6
    term:
      id: MONDO:0010484
      label: hearing loss, X-linked 6
  description: >-
    COL4A6-related DFNX6 is an X-linked hearing-loss subtype reported in
    molecular cohorts; the abstract-supported evidence identifies COL4A6 as one
    of the genes contributing to X-linked hereditary hearing loss.
  genes:
  - preferred_term: COL4A6
    term:
      id: hgnc:2208
      label: COL4A6
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the aggregate contribution of HL caused by genes on the X chromosome in
      this cohort was ~ 1.14% (22/1922), and POU3F4 variants caused ~ 59%
      (13/22) of these cases.
    explanation: >-
      This molecular epidemiology study supports the broader X-linked gene
      category that includes COL4A6 in the Falcon report, while the abstract
      does not provide COL4A6-specific phenotype details.
prevalence:
- population: Hereditary hearing loss
  percentage: Up to 2%
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      X-linked deafness (DFNX) is estimated to account for up to 2% of cases of
      hereditary hearing loss and occurs in both syndromic and non-syndromic
      forms.
    explanation: >-
      Review-level evidence provides the commonly cited contribution of DFNX to
      hereditary hearing loss.
- population: Chinese genetically solved hearing-loss cohort
  percentage: "1.14"
  notes: >-
    X-chromosome genes accounted for approximately 1.14% of genetically solved
    hearing-loss cases in a 3646-proband Chinese molecular epidemiology cohort.
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We obtained a diagnostic rate of 52.72% (1922/3646) among our patients;
      the aggregate contribution of HL caused by genes on the X chromosome in
      this cohort was ~ 1.14% (22/1922)
    explanation: >-
      The cohort directly quantifies the X-linked contribution among solved
      hereditary hearing-loss cases.
inheritance:
- name: X-linked inheritance
  inheritance_term:
    preferred_term: X-linked inheritance
    term:
      id: HP:0001417
      label: X-linked inheritance
  description: >-
    DFNX is caused by pathogenic variants in genes on the X chromosome.
    Hemizygous males are typically more severely affected, and heterozygous
    females may show variable expressivity.
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      X-linked HL was congenital or began during childhood in all cases, with
      representative audiological profiles or typical cochlear malformations in
      certain genes.
    explanation: >-
      The cohort describes X-linked hereditary hearing-loss cases and their
      early-onset clinical presentation.
pathophysiology:
- name: X-linked genetic heterogeneity in cochlear disease
  description: >-
    X-linked nonsyndromic hearing loss is not a single molecular mechanism but
    a category of X-chromosome gene defects affecting auditory development and
    function. Molecular diagnosis links the auditory phenotype to genes such as
    PRPS1, POU3F4, SMPX, AIFM1, and COL4A6.
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We also discussed the clinical features associated with X-linked
      non-syndromic HL-related genes based on a review of the literature.
    explanation: >-
      The study frames DFNX as a multi-gene X-linked hearing-loss category.
  downstream:
  - target: Sensorineural hearing impairment
    description: >-
      Gene-specific disruption of auditory development or function produces
      isolated hearing impairment.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:39272213
      reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        X-linked HL was congenital or began during childhood in all cases, with
        representative audiological profiles or typical cochlear malformations
        in certain genes.
      explanation: >-
        The cohort connects X-linked gene diagnoses with early-onset
        audiological profiles and malformations.
- name: POU3F4-related inner ear developmental malformation
  description: >-
    POU3F4 encodes a POU-family transcription factor required for middle and
    inner ear development. POU3F4 defects can disrupt inner-ear morphogenesis,
    producing incomplete partition type III and predisposing to perilymphatic
    gusher during otologic surgery.
  genes:
  - preferred_term: POU3F4
    term:
      id: hgnc:9217
      label: POU3F4
  biological_processes:
  - preferred_term: inner ear morphogenesis
    modifier: ABNORMAL
    term:
      id: GO:0042472
      label: inner ear morphogenesis
  - preferred_term: regulation of DNA-templated transcription
    modifier: ABNORMAL
    term:
      id: GO:0006355
      label: regulation of DNA-templated transcription
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      This gene codes for a transcription factor of the POU family that plays a
      major role in the development of the middle and inner ear.
    explanation: >-
      The review supports the developmental transcription-factor mechanism for
      POU3F4-related DFNX.
  downstream:
  - target: Incomplete partition type III
    description: >-
      Developmental disruption causes the characteristic IP-III inner-ear
      malformation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:37371790
      reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        The clinical features of POU3F4-related hearing loss include a
        pathognomonic malformation of the inner ear defined as incomplete
        partition of the cochlea type 3 (IP-III).
      explanation: >-
        The review directly links POU3F4-related hearing loss to IP-III.
- name: SMPX-related hair-cell mechanotransduction defect
  description: >-
    SMPX encodes a cytoskeleton-associated protein expressed in inner-ear hair
    cells. Model-organism evidence supports a role in hair-cell differentiation,
    kinocilium structure, and mechanotransduction, providing a cellular
    mechanism for progressive DFNX4 hearing loss.
  genes:
  - preferred_term: SMPX
    term:
      id: hgnc:11122
      label: SMPX
  cell_types:
  - preferred_term: Auditory hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  biological_processes:
  - preferred_term: detection of mechanical stimulus involved in sensory perception
    modifier: DECREASED
    term:
      id: GO:0050974
      label: detection of mechanical stimulus involved in sensory perception
  - preferred_term: cell projection organization
    modifier: ABNORMAL
    term:
      id: GO:0030030
      label: cell projection organization
  evidence:
  - reference: PMID:38570547
    reference_title: "Differentiation and functioning of the lateral line organ in zebrafish require Smpx activity."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The small muscle protein, X-linked (SMPX) gene encodes a
      cytoskeleton-associated protein, highly expressed in the inner ear hair
      cells (HCs), possibly regulating auditory function.
    explanation: >-
      The abstract supports SMPX expression in inner-ear hair cells and its
      likely auditory role.
  - reference: PMID:38570547
    reference_title: "Differentiation and functioning of the lateral line organ in zebrafish require Smpx activity."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Such phenotypes were associated with a significant reduction in the
      mechanotransduction activity of the neuromast HCs
    explanation: >-
      Zebrafish loss-of-function evidence supports reduced mechanotransduction
      as a cellular consequence of SMPX deficiency.
  downstream:
  - target: Progressive sensorineural hearing impairment
    description: >-
      Reduced hair-cell mechanotransduction provides a cellular route from SMPX
      deficiency to progressive sensorineural hearing impairment.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:38570547
      reference_title: "Differentiation and functioning of the lateral line organ in zebrafish require Smpx activity."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Such phenotypes were associated with a significant reduction in the
        mechanotransduction activity of the neuromast HCs
      explanation: >-
        Model-organism data connect SMPX deficiency with reduced hair-cell
        mechanotransduction, supporting the edge to progressive hearing
        impairment.
phenotypes:
- category: Clinical
  name: Sensorineural hearing impairment
  description: >-
    Hearing impairment is the defining clinical phenotype of DFNX and is often
    sensorineural. In current cohort evidence, X-linked cases were congenital
    or childhood onset.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      X-linked HL was congenital or began during childhood in all cases, with
      representative audiological profiles or typical cochlear malformations in
      certain genes.
    explanation: >-
      The cohort directly describes early onset of X-linked hereditary
      hearing-loss cases.
- category: Clinical
  name: Progressive sensorineural hearing impairment
  description: >-
    Progressive sensorineural hearing loss is especially emphasized for PRPS1
    and SMPX-related DFNX subtypes.
  phenotype_term:
    preferred_term: Progressive sensorineural hearing impairment
    term:
      id: HP:0000408
      label: Progressive sensorineural hearing impairment
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Variations in SMPX causing truncation of the protein product were
      associated with DFNX4, which resulted in typical audiological profiles
      before and after the age of 10 years
    explanation: >-
      The cohort summary supports an age-related audiological profile in
      SMPX-related DFNX4.
- category: Clinical
  name: Incomplete partition type III
  description: >-
    POU3F4-related DFNX2/DFN3 is associated with incomplete partition type III,
    a characteristic inner-ear malformation that affects surgical planning.
  subtype: DFNX2
  phenotype_term:
    preferred_term: Incomplete partition type III
    term:
      id: HP:0008554
      label: Cochlear malformation
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The clinical features of POU3F4-related hearing loss include a
      pathognomonic malformation of the inner ear defined as incomplete
      partition of the cochlea type 3 (IP-III).
    explanation: >-
      The review directly supports IP-III as the characteristic POU3F4-related
      malformation.
  - reference: PMID:38498189
    reference_title: "Research progress on incomplete partition type 3 inner ear malformation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Mutations in the POU3F4 gene emerge as the principal pathogenic
      contributors to IP-III anomalies
    explanation: >-
      The IP-III review independently supports POU3F4 as the principal genetic
      contributor to this malformation.
- category: Clinical
  name: Perilymphatic gusher during stapedectomy
  description: >-
    POU3F4-related DFNX2 can include perilymphatic gusher during otologic
    surgery, probably reflecting incomplete separation between the cochlea and
    internal auditory canal. No exact HPO term was identified locally, so this
    is retained as a named clinical phenotype without a broad substitute term.
  subtype: DFNX2
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Often, a perilymphatic gusher is observed upon stapedectomy during
      surgery, possibly as a consequence of an incomplete separation of the
      cochlea from the internal auditory canal.
    explanation: >-
      The POU3F4 review directly supports perilymphatic gusher as a
      DFNX2-relevant surgical phenotype.
genetic:
- name: PRPS1 pathogenic variants
  gene_term:
    preferred_term: PRPS1
    term:
      id: hgnc:9462
      label: PRPS1
  presence: Pathogenic
  association: Causal
  relationship_type: CAUSATIVE
  subtype: DFNX1
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      causative variants in PRPS1 and AIFM1 were mainly of the missense type,
      suggesting that phenotypic variability was correlated with the different
      effects that the replaced residues exert on structure and function.
    explanation: >-
      The cohort supports PRPS1 pathogenic variants as a cause of X-linked
      hereditary hearing loss.
- name: POU3F4 pathogenic variants
  gene_term:
    preferred_term: POU3F4
    term:
      id: hgnc:9217
      label: POU3F4
  presence: Pathogenic
  association: Causal
  relationship_type: CAUSATIVE
  subtype: DFNX2
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      POU3F4 is the gene most commonly associated with X-linked deafness
      (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked
      non-syndromic hearing loss.
    explanation: >-
      Review-level evidence supports POU3F4 as the most common DFNX gene.
- name: SMPX pathogenic variants
  gene_term:
    preferred_term: SMPX
    term:
      id: hgnc:11122
      label: SMPX
  presence: Pathogenic
  association: Causal
  relationship_type: CAUSATIVE
  subtype: DFNX4
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Variations in SMPX causing truncation of the protein product were
      associated with DFNX4, which resulted in typical audiological profiles
      before and after the age of 10 years
    explanation: >-
      The cohort supports truncating SMPX variants as DFNX4-associated.
- name: AIFM1 pathogenic variants
  gene_term:
    preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  presence: Pathogenic
  association: Causal
  relationship_type: CAUSATIVE
  subtype: DFNX5
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      causative variants in PRPS1 and AIFM1 were mainly of the missense type,
      suggesting that phenotypic variability was correlated with the different
      effects that the replaced residues exert on structure and function.
    explanation: >-
      The cohort supports AIFM1 pathogenic variants as a cause of X-linked
      hereditary hearing loss.
- name: COL4A6 pathogenic variants
  gene_term:
    preferred_term: COL4A6
    term:
      id: hgnc:2208
      label: COL4A6
  presence: Pathogenic
  association: Causal
  relationship_type: CAUSATIVE
  subtype: DFNX6
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      No phenotypic differences were identified in patients carrying POU3F4 or
      COL4A6 variants.
    explanation: >-
      The abstract specifically mentions patients carrying COL4A6 variants but
      gives limited COL4A6-specific mechanism or phenotype detail, so this
      assertion remains partial.
diagnosis:
- name: Audiologic evaluation with genomic testing
  description: >-
    Evaluation includes audiologic testing and molecular testing for X-linked
    hearing-loss genes. The recent Chinese cohort used next-generation
    sequencing and third-generation sequencing in a large hearing-loss cohort.
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We performed a molecular epidemiological investigation of X-linked
      hereditary HL based on next-generation sequencing and third-generation
      sequencing in 3646 unrelated patients with HL.
    explanation: >-
      This supports genomic testing as an implemented diagnostic approach in a
      large X-linked hereditary hearing-loss cohort.
treatments:
- name: Cochlear implantation for POU3F4/IP-III anatomy
  description: >-
    Cochlear implantation is a major intervention for severe POU3F4-related
    IP-III hearing loss, but the malformation increases surgical complexity and
    requires careful preoperative assessment and postoperative verification.
  treatment_term:
    preferred_term: cochlear implantation
    term:
      id: MAXO:0000451
      label: implantation
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:38498189
    reference_title: "Research progress on incomplete partition type 3 inner ear malformation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      cochlear implantation currently serving as the predominant therapeutic
      approach.
    explanation: >-
      The IP-III review supports cochlear implantation as the predominant
      therapeutic approach for this malformation-associated form of X-linked
      deafness.
- name: Genetic Counseling
  description: >-
    Genetic counseling is important for recurrence-risk counseling, sex-linked
    inheritance counseling, and genotype-informed management decisions in DFNX
    families.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: MAXO:0000079
      label: genetic counseling
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Analysis of the genotype-phenotype relationship is valuable for X-linked
      HL precise diagnostics and genetic counseling.
    explanation: >-
      The cohort conclusion directly supports genetic counseling as a
      management implication of genotype-phenotype analysis.
datasets: []
📚

References & Deep Research

Deep Research

1
Falcon ▸
1. Disease Information
Edison Scientific Literature 26 citations 2026-05-08T12:36:34.954187

1. Disease Information

1.1 Definition and overview

X-linked deafness (DFNX) refers to hereditary hearing loss caused by pathogenic variants on the X chromosome and includes both syndromic and nonsyndromic entities; “DFNX” is typically used for X-linked nonsyndromic hearing loss in the hereditary hearing-loss locus nomenclature (bernardinelli2023clinicalandmolecular pages 1-2, jiang2023advancesingene pages 1-2). Clinical expression is often sex-influenced: hemizygous males are most severely affected, while heterozygous females may show variable hearing loss due to X-chromosome inactivation effects (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5).

1.2 Key identifiers (gene/locus-level identifiers available in evidence)

A 2024 Orphanet Journal of Rare Diseases cohort analysis explicitly lists major DFNX gene–locus mappings (including MIM numbers) (feng2024genomicandphenotypic pages 1-2): - PRPS1: DFNX1 (MIM#304500) (feng2024genomicandphenotypic pages 1-2) - POU3F4: DFNX2 / DFN3 (MIM#304400); gene OMIM *300039 (bernardinelli2023clinicalandmolecular pages 1-2, bernardinelli2023clinicalandmolecular pages 5-7) - SMPX: DFNX4 (MIM#300066) (feng2024genomicandphenotypic pages 1-2) - AIFM1: DFNX5 (MIM#300614) (feng2024genomicandphenotypic pages 1-2) - COL4A6: DFNX6 (MIM#303630) (feng2024genomicandphenotypic pages 1-2)

1.3 Synonyms / alternative names

  • “X-linked deafness (DFNX)” (broad category including syndromic and nonsyndromic) (bernardinelli2023clinicalandmolecular pages 1-2)
  • “X-linked nonsyndromic hearing loss (DFNX)” (feng2024genomicandphenotypic pages 1-2)
  • POU3F4-related X-linked deafness type 3: DFN3 (also referenced as DFNX2) (bernardinelli2023clinicalandmolecular pages 5-7, bernardinelli2023clinicalandmolecular pages 20-21)

1.4 Evidence source type

The information summarized here is derived from aggregated disease-level resources (peer-reviewed reviews) and cohort-based clinical genetics studies (large case series) rather than EHR-only summaries (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 1-2).

2. Etiology

2.1 Disease causal factors

Primary cause: germline pathogenic variation in X-chromosome genes important for auditory development and/or cochlear cellular function (feng2024genomicandphenotypic pages 1-2, bernardinelli2023clinicalandmolecular pages 1-2).

2.2 Risk factors

  • Genetic risk factor: carrying pathogenic variants in DFNX genes (e.g., POU3F4, PRPS1, SMPX, AIFM1, COL4A6) (feng2024genomicandphenotypic pages 1-2).
  • Sex as a modifier: males typically more severely affected due to hemizygosity; females may exhibit variable expressivity due to skewed X-inactivation (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5).

2.3 Protective factors / gene–environment interaction

No DFNX-specific protective factors or gene–environment interaction data were identified in the retrieved evidence.

3. Phenotypes (HPO-aligned)

3.1 Core phenotype domain

  • Hearing impairment / sensorineural hearing loss (HP:0000365 / HP:0000407) is the defining phenotype across DFNX genes (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5).

3.2 Age of onset and severity (recent cohort statistics)

In a 2024 Chinese cohort of 3646 unrelated patients with hearing loss (HL), X-linked diagnoses were ~1.14% of genetically solved cases (22/1922) and clinical onset among X-linked HL cases was congenital or childhood in all cases; severity in evaluated probands with X-linked variants was predominantly severe–profound (25/29) (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5).

3.3 Gene-associated phenotype highlights

POU3F4 (DFNX2/DFN3)

  • Often severe to profound hearing loss with pathognomonic inner-ear malformation: incomplete partition type III (IP-III) (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5).
  • Imaging features reported include absent/defective modiolus and interscalar septa, dilated internal auditory canal (IAC), and deficient bony separation between cochlea and IAC (feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 6-7). The radiologic comparison (normal vs IP-III) is shown in the retrieved figure (bernardinelli2023clinicalandmolecular media 04c7488e).
  • Suggested HPO terms: Abnormality of the inner ear morphology (HP:0000364), Cochlear malformation (HP:0008551), Perilymphatic gusher (HP term not universally standardized; clinical descriptor supported by evidence) (bernardinelli2023clinicalandmolecular pages 1-2, jung2023geneticcharacteristicsand pages 1-2).

PRPS1 (DFNX1)

  • Reported as a phenotypic spectrum ranging from isolated HL to more severe syndromes; within the provided cohort summary, male cases can show progressive hearing loss with onset ranging from congenital through teenage years and severity from moderate to profound (feng2024genomicandphenotypic pages 4-5).
  • Suggested HPO terms: Progressive sensorineural hearing impairment (HP:0000408) (feng2024genomicandphenotypic pages 4-5).

SMPX (DFNX4)

  • Associated with progressive nonsyndromic hearing loss; truncating variants are associated with typical audiological profiles in childhood (before/after age 10), whereas nontruncating changes were noted as linking more often to distal myopathy phenotypes (not nonsyndromic HL) (feng2024genomicandphenotypic pages 1-2).
  • Female carriers may have variable, later-onset hearing loss (often 4th–5th decade), from unilateral/normal to mild–moderate symmetric/asymmetric loss (feng2024genomicandphenotypic pages 6-7).
  • Suggested HPO terms: Progressive hearing impairment (HP:0000408), Asymmetric sensorineural hearing impairment (HP:0008619).

AIFM1 (DFNX5)

  • Can present as auditory neuropathy with postsynaptic lesion and progressive auditory dyssynchrony; cochlear nerve hypoplasia may occur (feng2024genomicandphenotypic pages 10-12).
  • Suggested HPO terms: Auditory neuropathy (HP:0030781), Cochlear nerve hypoplasia (HP:0030795).

COL4A6 (DFNX6)

  • In the 2024 cohort, no phenotypic differences were identified among POU3F4 or COL4A6 carriers, but cochlear malformation (e.g., cochlear hypoplasia) was described for a COL4A6 variant example (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4).

3.4 Quality-of-life impact

Direct QoL instrument data (EQ-5D/SF-36/PROMIS) specific to DFNX were not identified in the retrieved evidence; however, severe–profound congenital/childhood hearing loss implies major communication and developmental impacts, motivating early diagnosis and intervention (feng2024genomicandphenotypic pages 4-5).

4. Genetic / Molecular Information

4.1 Causal genes

A recent large cohort review of X-linked hereditary HL highlights the principal DFNX genes: PRPS1, POU3F4, SMPX, AIFM1, COL4A6 (feng2024genomicandphenotypic pages 1-2). POU3F4 is emphasized as the most common gene for X-linked nonsyndromic HL in reviews and cohorts (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 1-2).

4.2 Variant types and functional consequences (by gene)

POU3F4 (DFNX2/DFN3)

POU3F4 variants include missense, nonsense, frameshift (single coding exon), as well as larger deletions/insertions/inversions and upstream regulatory deletions affecting expression (bernardinelli2023clinicalandmolecular pages 5-7). The 2024 cohort further reports CNVs including whole-gene deletion (~165 kb) and notes clustering of pathogenic changes in the POU-specific domain and homeodomain with frequent truncation outcomes (feng2024genomicandphenotypic pages 2-4, feng2024genomicandphenotypic pages 6-7). Functionally characterized variants can show abnormal subcellular localization and impaired nuclear trafficking/transcriptional activity (bernardinelli2023clinicalandmolecular pages 5-7).

PRPS1 (DFNX1) and AIFM1 (DFNX5)

In the 2024 cohort analysis, causative variants in PRPS1 and AIFM1 were mainly missense, and phenotypic variability was proposed to correlate with residue-level structural/function effects (feng2024genomicandphenotypic pages 1-2).

SMPX (DFNX4)

SMPX DFNX4 is described as X-linked dominant NSHL with a reported set of 15 causative variants, mostly truncating and splice-site variants with a minority nontruncating/missense variants (feng2024genomicandphenotypic pages 6-7). A genotype–phenotype distinction was noted in which truncating variants were associated with DFNX4 hearing-loss profiles, while nontruncating variants were linked to distal myopathy phenotypes (feng2024genomicandphenotypic pages 1-2).

4.3 Modifier genes / epigenetics

No specific modifier-gene findings or epigenetic mechanisms were identified in the retrieved DFNX-focused evidence; sex-related variability due to X-inactivation is an important mechanism for phenotypic differences in females (feng2024genomicandphenotypic pages 4-5).

5. Environmental Information

DFNX is primarily genetic. No DFNX-specific environmental contributors were identified in the retrieved evidence.

6. Mechanism / Pathophysiology (with ontology suggestions)

6.1 POU3F4: developmental malformation mechanism leading to IP-III

POU3F4 encodes a transcription factor with a major role in middle/inner ear development (bernardinelli2023clinicalandmolecular pages 1-2). The characteristic DFNX2/DFN3 clinical chain supported by the evidence is: 1) POU3F4 pathogenic variant → 2) altered transcription factor function/expression (including mislocalization for some variants) → 3) disrupted ear development and characteristic IP-III cochlear/IAC anatomy → 4) severe congenital/early hearing loss and surgery-specific risks such as CSF/perilymphatic “gusher” due to abnormal cochlea–IAC communication (bernardinelli2023clinicalandmolecular pages 5-7, feng2024genomicandphenotypic pages 4-5, jung2023geneticcharacteristicsand pages 1-2).

Ontology suggestions - UBERON: cochlea (UBERON:0001766), internal auditory canal (UBERON:0001675), stria vascularis (UBERON:0001845). - CL (cell types): otic mesenchyme cell (not always present as a distinct CL label in curated ontologies; mechanistic role supported by review and IP-III literature), cochlear supporting cell, spiral ganglion neuron. - GO biological process: inner ear development; regulation of transcription.

6.2 SMPX: hair-cell/kinocilium and mechanotransduction phenotype (model organism evidence; 2024)

A 2024 Scientific Reports study provides in vivo functional evidence that smpx is required for mechanosensory hair-cell development/function in zebrafish lateral line neuromasts, with Smpx localized to hair-cell cytoplasm and kinocilium and loss-of-function producing abnormal kinocilia and reduced mechanotransduction (e.g., reduced FM dye uptake) (diana2024differentiationandfunctioning pages 1-2, diana2024differentiationandfunctioning pages 2-3). This supports a causal chain: 1) SMPX loss-of-function → 2) impaired hair-cell structural integrity (including kinocilium changes) → 3) reduced mechanotransduction → 4) progressive hearing loss in humans (DFNX4) (diana2024differentiationandfunctioning pages 1-2).

Direct abstract-supported statement (model evidence): the paper describes SMPX as “highly expressed in the inner ear hair cells (HCs)” and notes that SMPX mutations have been associated with “X-chromosomal progressive non syndromic hearing loss in humans” (diana2024differentiationandfunctioning pages 1-2).

Ontology suggestions - CL: sensory hair cell (CL:0000601). - GO: sensory perception of sound; mechanotransduction; cilium organization. - UBERON: organ of Corti (UBERON:0001894).

6.3 AIFM1: auditory neuropathy phenotype

The 2024 DFNX cohort synthesis notes that AIFM1-related auditory neuropathy involves postsynaptic lesions and progressive dyssynchrony; cochlear nerve hypoplasia may occur (feng2024genomicandphenotypic pages 10-12). Mechanistically, this points to neural/synaptic dysfunction downstream of cochlear mechanics.

7. Anatomical Structures Affected

7.1 Primary structures

  • Inner ear/cochlea (UBERON:0001766) across DFNX conditions (feng2024genomicandphenotypic pages 1-2).
  • IAC–cochlea interface and modiolus in POU3F4/IP-III (feng2024genomicandphenotypic pages 4-5, bernardinelli2023clinicalandmolecular media 04c7488e).

7.2 Cell types (evidence-supported)

  • Sensory hair cells (especially for SMPX) (diana2024differentiationandfunctioning pages 1-2).

7.3 Subcellular compartments

SMPX localization includes the kinocilium and cytoplasm in zebrafish hair cells, supporting involvement of ciliary and cytoskeletal structures (diana2024differentiationandfunctioning pages 2-3).

8. Temporal Development

8.1 Onset

In a large 2024 molecular epidemiology study, X-linked hereditary HL cases were congenital or began in childhood (feng2024genomicandphenotypic pages 1-2). For SMPX, female carrier onset may occur later (4th–5th decade) (feng2024genomicandphenotypic pages 6-7).

8.2 Progression

  • Progressive course is highlighted for PRPS1 male cases and SMPX DFNX4 (feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 6-7).

9. Inheritance and Population

9.1 Inheritance patterns

  • DFNX conditions are X-linked; DFNX phenotypes show sex-related differences due to X-inactivation (feng2024genomicandphenotypic pages 4-5).
  • SMPX (DFNX4) is described as X-linked dominant nonsyndromic hearing loss (feng2024genomicandphenotypic pages 6-7).

9.2 Epidemiology (quantitative data from recent studies)

  • A 2023 review estimates DFNX accounts for up to ~2% of hereditary hearing loss and that POU3F4 accounts for ~50% of X-linked nonsyndromic hearing loss (bernardinelli2023clinicalandmolecular pages 1-2).
  • In a 2024 Chinese cohort, the aggregate contribution of X-chromosome genes to genetically solved HL was ~1.14% (22/1922), with POU3F4 representing ~59% (13/22) of those X-linked diagnosed cases (feng2024genomicandphenotypic pages 1-2).

Population variant frequencies (e.g., gnomAD allele frequencies), founder effects, and carrier frequencies were not available in the retrieved evidence set.

10. Diagnostics

10.1 Clinical tests and phenotyping

A recent large cohort used: - Audiologic assessment including PTA, ABR, DPOAE, and clinical severity grading (feng2024genomicandphenotypic pages 2-4). - Temporal bone imaging (HRCT / MRI) to detect malformations such as IP-III (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5).

10.2 Genetic testing strategies (real-world implementation)

In the 2024 Chinese study, genetic diagnosis relied on a combination of a 227-gene panel (majority of cases) and whole-exome sequencing, with third-generation sequencing (TGS) used when prior NGS approaches did not yield a diagnosis; the overall molecular diagnostic yield across 3646 probands was 52.72% (1922/3646) (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4).

10.3 Differential diagnosis considerations (DFNX vs syndromic X-linked disorders)

The DFNX framework explicitly distinguishes X-linked nonsyndromic HL genes from syndromic X-linked conditions with HL (e.g., Norrie, Alport) (feng2024genomicandphenotypic pages 1-2).

10.4 Screening

The evidence emphasizes early genetic diagnosis and monitoring (especially where progression is expected) but did not provide specific newborn screening or carrier screening program metrics.

11. Outcome / Prognosis

11.1 Hearing outcomes and intervention response

  • Cochlear implantation in IP-III: In a 2023 cohort of 11 IP-III patients, 9/11 had POU3F4 pathogenic variants, all surgeries had CSF gushers, and postoperative auditory performance (CAP scores) improved significantly (jung2023geneticcharacteristicsand pages 1-2).
  • CI outcomes in IP-III are described as variable across reports, and long-term device/linguistic performance may diverge from typical pediatric CI populations (xu2024researchprogresson pages 2-4).

No DFNX-specific mortality or life-expectancy impacts were identified.

12. Treatment

12.1 Standard-of-care treatments and implementations

  • Hearing aids and cochlear implantation (CI) are the principal current interventions in DFNX populations, selected based on severity and benefit (feng2024genomicandphenotypic pages 10-12, feng2024genomicandphenotypic pages 4-5).

12.2 DFNX2/DFN3 (POU3F4) surgical considerations (real-world constraints)

POU3F4/IP-III malformation creates high-risk anatomy (direct cochlea–IAC communication), leading to: - Perilymphatic/CSF gusher risk during surgery (highlighted as universal in the 2023 IP-III CI cohort) (jung2023geneticcharacteristicsand pages 1-2). - Electrode misplacement into the IAC risk; recommendations include specialized electrodes (e.g., “cork” stopper / rings), intra-operative CT confirmation, and other intraoperative sealing/packing strategies (xu2024researchprogresson pages 2-4, feng2024genomicandphenotypic pages 10-12).

12.3 Advanced therapeutics and experimental approaches (2023–2024 landscape)

Gene therapy: state of the field and applicability to DFNX

A 2023 Molecular Therapy review summarizes that inner ear gene therapy strategies typically include gene replacement, gene suppression, and gene editing, and emphasizes the practical advantage of local inner-ear delivery due to its confined fluid-filled anatomy (jiang2023advancesingene pages 1-2, jiang2023advancesingene pages 13-14). It also states that “DFNA, DFNB, and DFNX” denote autosomal dominant, autosomal recessive, and X-linked deafness classifications, respectively (jiang2023advancesingene pages 1-2).

Clinical translation in 2023–2024 (trial reality): the retrieved clinical-trial landscape is currently dominated by autosomal recessive targets (notably OTOF/DFNB9) rather than DFNX genes. Examples include: - DB-OTO (AAV-based) in children/infants with OTOF-related hearing loss (ClinicalTrials.gov NCT05788536, recruiting) (clinical trials search results). - Additional OTOF programs (e.g., NCT06722170) and an RNA base-editing study (NCT06025032, withdrawn) (clinical trials search results).

No DFNX gene-targeted interventional gene therapy trial was identified in the retrieved ClinicalTrials.gov results.

12.4 MAXO term suggestions

  • Hearing aid fitting (MAXO term not retrieved here; concept: hearing aid therapy) (feng2024genomicandphenotypic pages 4-5)
  • Cochlear implantation (MAXO concept) (jung2023geneticcharacteristicsand pages 1-2)
  • Genetic counseling (MAXO concept) (feng2024genomicandphenotypic pages 1-2)

13. Prevention

No DFNX-specific primary prevention is established (genetic etiology). Secondary/tertiary prevention is largely through early identification, timely hearing rehabilitation, and genotype-informed surgical planning (feng2024genomicandphenotypic pages 4-5, jung2023geneticcharacteristicsand pages 1-2).

14. Other species / natural disease

No naturally occurring DFNX-analog disease in companion animals was identified in the retrieved evidence.

15. Model organisms

  • Zebrafish smpx loss-of-function provides a 2024 in vivo mechanistic model showing impaired mechanosensory hair-cell development/function and reduced mechanotransduction, relevant to SMPX DFNX4 pathogenesis (diana2024differentiationandfunctioning pages 1-2, diana2024differentiationandfunctioning pages 2-3).

Expert synthesis (2023–2024 authoritative interpretation)

1) POU3F4 is the dominant DFNX gene in practice: reviews estimate POU3F4 accounts for ~50% of X-linked nonsyndromic HL and DFNX overall contributes up to ~2% of hereditary HL; a large 2024 cohort similarly found POU3F4 comprised ~59% of solved X-linked cases (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 1-2). This convergence supports prioritizing POU3F4 in DFNX diagnostic algorithms and pre-surgical planning. 2) Genotype-informed otologic surgery is a real-world necessity: IP-III anatomy produces predictable intraoperative risks (CSF gusher, electrode misplacement). Cohort-level surgical evidence shows universal CSF gusher in IP-III CI and significant functional improvement post-CI, supporting CI as beneficial but requiring specialized technique and counseling (jung2023geneticcharacteristicsand pages 1-2, xu2024researchprogresson pages 2-4). 3) Therapeutic frontier is moving, but DFNX-specific gene therapy is not yet clinical: 2023–2024 gene therapy progress is substantial in hereditary HL broadly (vectors, routes, editing strategies), but current registered interventional trials in retrieved evidence largely target DFNB9/OTOF rather than DFNX (jiang2023advancesingene pages 1-2).

Summary tables and key visuals

The following table consolidates DFNX gene–phenotype–variant–management mappings extracted from the evidence.

Gene DFNX subtype / OMIM MIM number (as reported in evidence) Protein/function (brief) Typical phenotype (onset, severity, progression, imaging) Common variant types (missense/truncating/CNV/regulatory) Notes on management (CI, surgical risk) Key recent/authoritative sources with year, DOI/URL, and PMID if present in text
PRPS1 DFNX1; MIM#304500 (feng2024genomicandphenotypic pages 1-2) Phosphoribosyl pyrophosphate synthetase 1; enzyme in nucleotide/purine biosynthesis spectrum disorders (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5) Congenital to childhood onset in cohort; male patients can show progressive hearing loss ranging from moderate to profound; may present as isolated HL or part of broader PRPS1 spectrum (feng2024genomicandphenotypic pages 4-5) Predominantly missense; one duplication variant noted (c.937_940dup) (feng2024genomicandphenotypic pages 4-5) Hearing aids may be insufficient in some cases; cochlear implantation (CI) improved hearing and communication in cohort when HA benefit was limited, but gene-specific quantitative CI data for PRPS1 were not provided (feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 2-4) Feng et al., 2024, Orphanet J Rare Dis; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5)
POU3F4 DFNX2 / DFN3; OMIM #304400; gene OMIM *300039 (bernardinelli2023clinicalandmolecular pages 1-2, bernardinelli2023clinicalandmolecular pages 5-7, feng2024genomicandphenotypic pages 6-7) POU-family transcription factor critical for middle/inner ear development (otic mesenchyme/cochlear development) (bernardinelli2023clinicalandmolecular pages 1-2, xu2024researchprogresson pages 1-2) Usually congenital or childhood-onset, often severe to profound HL; hallmark imaging is incomplete partition type III (IP-III) with absent modiolus/interscalar septa, dilated IAC, abnormal communication between cochlea and IAC; can have mixed or sensorineural HL (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 6-7, xu2024researchprogresson pages 2-4) Missense, nonsense, frameshift, indels, structural variants/CNVs, whole-gene deletions, upstream regulatory deletions/insertions/inversions (bernardinelli2023clinicalandmolecular pages 5-7, feng2024genomicandphenotypic pages 2-4, jung2023geneticcharacteristicsand pages 1-2) Most important real-world management issue in DFNX: CI is standard but technically difficult in IP-III. Risks include CSF/perilymphatic gusher and electrode misplacement into the IAC; pre-op CT/MRI, intra-op imaging, sealing cochleostomy, and shorter/straight or special stopper/ring electrodes are recommended. In one 2023 series of 11 IP-III patients, all CI surgeries had CSF gushers and CAP scores improved postoperatively (jung2023geneticcharacteristicsand pages 1-2, xu2024researchprogresson pages 2-4, feng2024genomicandphenotypic pages 10-12) Bernardinelli et al., 2023, Biomedicines; DOI: 10.3390/biomedicines11061695; URL: https://doi.org/10.3390/biomedicines11061695; PMID: —. Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: —. Jung et al., 2023; DOI: 10.21053/ceo.2023.00864; URL: https://doi.org/10.21053/ceo.2023.00864; PMID: —. Xu et al., 2024; DOI: 10.1007/s00405-024-08555-7; URL: https://doi.org/10.1007/s00405-024-08555-7; PMID: — (bernardinelli2023clinicalandmolecular pages 1-2, bernardinelli2023clinicalandmolecular pages 5-7, jung2023geneticcharacteristicsand pages 1-2, xu2024researchprogresson pages 2-4)
SMPX DFNX4; MIM#300066 (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7) Small muscle protein, X-linked; cytoskeleton-associated protein highly expressed in inner-ear hair cells, linked to hair-cell differentiation/maintenance and mechanotransduction (diana2024differentiationandfunctioning pages 1-2, diana2024differentiationandfunctioning pages 2-3) Typically progressive NSHL; truncating variants associated with characteristic audiological profiles before and after age 10; female carriers may show variable expressivity, often later onset (4th–5th decade), mild–moderate, symmetric or asymmetric HL; no signature malformation emphasized (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7) Reported pathogenic spectrum includes truncating variants (10/15), splice-site variants (3/15), and a small number of nontruncating/missense variants; truncating variants linked to DFNX4, whereas nontruncating variants have been associated with distal myopathy (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7) Standard hearing rehabilitation applies; no DFNX4-specific CI risk profile reported in the provided evidence. Mechanistic animal work supports future targetability by molecular therapies, but no DFNX4 clinical gene therapy trial was identified here (feng2024genomicandphenotypic pages 1-2, diana2024differentiationandfunctioning pages 1-2) Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: —. Diana et al., 2024, Sci Rep; DOI: 10.1038/s41598-024-58138-z; URL: https://doi.org/10.1038/s41598-024-58138-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7, diana2024differentiationandfunctioning pages 1-2)
AIFM1 DFNX5; MIM#300614 (feng2024genomicandphenotypic pages 1-2) Apoptosis-inducing factor, mitochondria-associated; evidence emphasizes structural/functional residue effects and auditory-neuropathy phenotype (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 10-12) Congenital or childhood-onset X-linked HL in cohort; causative variants mainly missense; associated with auditory neuropathy, postsynaptic lesions, progressive auditory dyssynchrony, and sometimes cochlear nerve hypoplasia (CNH) (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 10-12) Predominantly missense (feng2024genomicandphenotypic pages 1-2) CI may have limited success in AIFM1-related auditory neuropathy compared with some other genetic etiologies; genotype can help guide expectations and treatment choice (feng2024genomicandphenotypic pages 10-12) Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 10-12)
COL4A6 DFNX6; MIM#303630 (feng2024genomicandphenotypic pages 1-2) Type IV collagen alpha-6 chain; extracellular matrix/basement membrane component (function not elaborated in detail in provided evidence) (feng2024genomicandphenotypic pages 1-2) Congenital or childhood-onset HL in cohort; no clear phenotypic differences highlighted among carriers in the 2024 Chinese series; can be associated with cochlear malformation, with one reported example of cochlear hypoplasia and profound SNHL (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4) Specific recurrent class not summarized in detail in provided evidence; sequence variants reported, including missense example c.1456G>A (feng2024genomicandphenotypic pages 2-4) CI can be successful in some malformation-associated DFNX cases; the evidence specifically contrasts better potential CI outcomes in some structural-gene cases with poorer results in AIFM1 auditory neuropathy, but COL4A6-specific outcome statistics were not provided (feng2024genomicandphenotypic pages 10-12, feng2024genomicandphenotypic pages 2-4) Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4)

Table: This table summarizes the principal genes and loci implicated in X-linked nonsyndromic hearing loss, with phenotype, variant spectrum, and management implications drawn only from the provided evidence. It is useful for rapid comparison of DFNX subtypes and for linking genotype to imaging and cochlear implant considerations.

A radiologic comparison figure of normal cochlea vs IP-III and a POU3F4 variant summary table were retrieved from a 2023 review; these support the hallmark IP-III malformation and the breadth of reported variant types (bernardinelli2023clinicalandmolecular media 04c7488e, bernardinelli2023clinicalandmolecular media 46a2f715).

Notes on evidence gaps

  • PMIDs were not present in the retrieved text excerpts for the key sources; DOIs and journal publication months/years are provided where available.
  • MONDO/Orphanet/ICD/MeSH IDs for the umbrella “X-linked nonsyndromic hearing loss” term were not retrieved in this tool run.
  • Population allele frequencies (gnomAD) and founder variants were not identified in the retrieved evidence.

References

  1. (bernardinelli2023clinicalandmolecular pages 1-2): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  2. (feng2024genomicandphenotypic pages 1-2): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  3. (jiang2023advancesingene pages 1-2): Luoying Jiang, Daqi Wang, Yingzi He, and Yilai Shu. Advances in gene therapy hold promise for treating hereditary hearing loss. Molecular Therapy, 31:934-950, Apr 2023. URL: https://doi.org/10.1016/j.ymthe.2023.02.001, doi:10.1016/j.ymthe.2023.02.001. This article has 127 citations and is from a highest quality peer-reviewed journal.

  4. (feng2024genomicandphenotypic pages 4-5): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  5. (bernardinelli2023clinicalandmolecular pages 5-7): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  6. (bernardinelli2023clinicalandmolecular pages 20-21): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  7. (feng2024genomicandphenotypic pages 6-7): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  8. (bernardinelli2023clinicalandmolecular media 04c7488e): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  9. (jung2023geneticcharacteristicsand pages 1-2): Jinsei Jung, Se A Lee, Un-Kyung Kim, In Seok Moon, Heon Yung Gee, and Jae Young Choi. Genetic characteristics and audiological performance after cochlear implantation in patients with incomplete partition type iii. Clinical and Experimental Otorhinolaryngology, 16:403-406, Nov 2023. URL: https://doi.org/10.21053/ceo.2023.00864, doi:10.21053/ceo.2023.00864. This article has 1 citations and is from a peer-reviewed journal.

  10. (feng2024genomicandphenotypic pages 10-12): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  11. (feng2024genomicandphenotypic pages 2-4): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  12. (diana2024differentiationandfunctioning pages 1-2): Alberto Diana, Anna Ghilardi, and Luca Del Giacco. Differentiation and functioning of the lateral line organ in zebrafish require smpx activity. Scientific Reports, Apr 2024. URL: https://doi.org/10.1038/s41598-024-58138-z, doi:10.1038/s41598-024-58138-z. This article has 1 citations and is from a peer-reviewed journal.

  13. (diana2024differentiationandfunctioning pages 2-3): Alberto Diana, Anna Ghilardi, and Luca Del Giacco. Differentiation and functioning of the lateral line organ in zebrafish require smpx activity. Scientific Reports, Apr 2024. URL: https://doi.org/10.1038/s41598-024-58138-z, doi:10.1038/s41598-024-58138-z. This article has 1 citations and is from a peer-reviewed journal.

  14. (xu2024researchprogresson pages 2-4): Kaifan Xu, Yun Xiao, Jianfen Luo, Xiuhua Chao, Ruijie Wang, Zhaoming Fan, Haibo Wang, and Lei Xu. Research progress on incomplete partition type 3 inner ear malformation. European Archives of Oto-Rhino-Laryngology, 281:3943-3948, Mar 2024. URL: https://doi.org/10.1007/s00405-024-08555-7, doi:10.1007/s00405-024-08555-7. This article has 5 citations and is from a peer-reviewed journal.

  15. (jiang2023advancesingene pages 13-14): Luoying Jiang, Daqi Wang, Yingzi He, and Yilai Shu. Advances in gene therapy hold promise for treating hereditary hearing loss. Molecular Therapy, 31:934-950, Apr 2023. URL: https://doi.org/10.1016/j.ymthe.2023.02.001, doi:10.1016/j.ymthe.2023.02.001. This article has 127 citations and is from a highest quality peer-reviewed journal.

  16. (xu2024researchprogresson pages 1-2): Kaifan Xu, Yun Xiao, Jianfen Luo, Xiuhua Chao, Ruijie Wang, Zhaoming Fan, Haibo Wang, and Lei Xu. Research progress on incomplete partition type 3 inner ear malformation. European Archives of Oto-Rhino-Laryngology, 281:3943-3948, Mar 2024. URL: https://doi.org/10.1007/s00405-024-08555-7, doi:10.1007/s00405-024-08555-7. This article has 5 citations and is from a peer-reviewed journal.

  17. (bernardinelli2023clinicalandmolecular media 46a2f715): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.